Skip to Content
Merck
CN
  • Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding.

Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding.

Biochimica et biophysica acta (2007-01-19)
Joshua D Dowell, Shih-Chong Tsai, Dora C Dias-Santagata, Hidehiro Nakajima, Zhuo Wang, Wuqiang Zhu, Loren J Field
ABSTRACT

p193/CUL7 is an E3 ubiquitin ligase initially identified as an SV40 Large T Antigen binding protein. Expression of a dominant interfering variant of mouse p193/CUL7 (designated 1152stop) conferred resistance to MG132- and etoposide-induced apoptosis in U2OS cells. Immune precipitation/Western analyses revealed that endogenous p193/CUL7 formed a complex with Parc (a recently identified parkin-like ubiquitin ligase) and p53. Apoptosis resistance did not result from 1152stop-mediated disruption of the endogenous p193/CUL7 binding partners. Moreover, 1152stop molecule did not directly bind to endogenous p193/CUL7, Parc or p53. These data suggested a role for p193/CUL7 in the regulation of apoptosis independently of p53 and Parc activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-p53 (Ab-7) (Pantropic) Sheep pAb, liquid, Calbiochem®